Serveur d'exploration sur la COVID en France - Analysis (France)

Index « Auteurs » - entrée « Camille Aubry »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Camelia C T Lina Jolde < Camille Aubry < Camille Besombes  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000003 (2020) Matthieu Million [France] ; Jean-Christophe Lagier [France] ; Philippe Gautret [France] ; Philippe Colson [France] ; Pierre-Edouard Fournier [France] ; Sophie Amrane [France] ; Marie Hocquart [France] ; Morgane Mailhe [France] ; Vera Esteves-Vieira [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Florian Correard [France] ; Audrey Giraud-Gatineau [France] ; Yanis Roussel [France] ; Cyril Berenger [France] ; Nadim Cassir [France] ; Piseth Seng [France] ; Christine Zandotti [France] ; Catherine Dhiver [France] ; Isabelle Ravaux [France] ; Christelle Tomei [France] ; Carole Eldin [France] ; Hervé Tissot-Dupont [France] ; Stéphane Honoré [France] ; Andreas Stein [France] ; Alexis Jacquier [France] ; Jean-Claude Deharo [France] ; Eric Chabrière [France] ; Anthony Levasseur [France] ; Florence Fenollar [France] ; Jean-Marc Rolain [France] ; Yolande Obadia [France] ; Philippe Brouqui [France] ; Michel Drancourt [France] ; Bernard La Scola [France] ; Philippe Parola [France] ; Didier Raoult [France]Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.
000005 (2020) Jean Christophe Lagier [France] ; Philippe Colson [France] ; Hervé Tissot Dupont [France] ; Jérôme Salomon [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Frédérique Gouriet [France] ; Sophie Baron [France] ; Pierre Dudouet [France] ; Rémi Flores [France] ; Lucie Ailhaud [France] ; Philippe Gautret [France] ; Philippe Parola [France] ; Bernard La Scola [France] ; Didier Raoult [France] ; Philippe Brouqui [France]Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine?
000006 (2020) Philippe Gautret [France] ; Jean-Christophe Lagier [France] ; Philippe Parola [France] ; Van Thuan Hoang [Viêt Nam] ; Line Meddeb [France] ; Jacques Sevestre [France] ; Morgane Mailhe [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Sophie Amrane [France] ; Piseth Seng [France] ; Marie Hocquart [France] ; Carole Eldin [France] ; Julie Finance [France] ; Vera Esteves Vieira [France] ; Hervé Tissot Tissot-Dupont [France] ; Stéphane Honoré [France] ; Andreas Stein [France] ; Matthieu Million [France] ; Philippe Colson [France] ; Bernard La Scola [France] ; Véronique Veit [France] ; Alexis Jacquier [France] ; Jean-Claude Deharo [France] ; Michel Drancourt [France] ; Pierre Edouard Fournier [France] ; Jean-Marc Rolain [France] ; Philippe Brouqui [France] ; Didier Raoult [France]Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study.

List of associated KwdEn.i

Nombre de
documents
Descripteur
3Adult (MeSH)
3Aged (MeSH)
3Female (MeSH)
3France (MeSH)
3Humans (MeSH)
3Male (MeSH)
3Middle Aged (MeSH)
3Pandemics (MeSH)
3Young Adult (MeSH)
2Adolescent (MeSH)
2Aged, 80 and over (MeSH)
2Azithromycin (therapeutic use)
2Coronavirus Infections (drug therapy)
2Drug Therapy, Combination (MeSH)
2Hydroxychloroquine (therapeutic use)
2Pneumonia, Viral (drug therapy)
2Viral Load (MeSH)
1Antiviral Agents (administration & dosage)
1Antiviral Agents (adverse effects)
1Antiviral Agents (therapeutic use)
1Azithromycin (administration & dosage)
1Azithromycin (adverse effects)
1Betacoronavirus (MeSH)
1Betacoronavirus (drug effects)
1Betacoronavirus (genetics)
1Child (MeSH)
1Child, Preschool (MeSH)
1Clinical Laboratory Techniques (MeSH)
1Coronavirus Infections (diagnosis)
1Coronavirus Infections (mortality)
1Coronavirus Infections (virology)
1Follow-Up Studies (MeSH)
1Hydroxychloroquine (administration & dosage)
1Hydroxychloroquine (adverse effects)
1Infant (MeSH)
1Infant, Newborn (MeSH)
1Nasopharynx (virology)
1Nose (MeSH)
1Pharynx (MeSH)
1Pilot Projects (MeSH)
1Pneumonia, Viral (diagnosis)
1Pneumonia, Viral (mortality)
1Pneumonia, Viral (virology)
1Polymerase Chain Reaction (MeSH)
1Quarantine (MeSH)
1RNA, Viral (isolation & purification)
1Real-Time Polymerase Chain Reaction (MeSH)
1Retrospective Studies (MeSH)
1Reverse Transcriptase Polymerase Chain Reaction (MeSH)
1Sputum (MeSH)
1Time Factors (MeSH)
1Travel (MeSH)
1Treatment Outcome (MeSH)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Camille Aubry" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Camille Aubry" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Camille Aubry
}}

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021